Theravance - TBPH Operatsion marja

TBPH (theravance.com) - kompaniyaning tovar belgisi

Theravance Biopharma (TBPH) uchun risklar royalti to'lovlarining tebranishlari va ampreloxetin sinovlarining natijalari bilan bog'liq. Sanoat gigantlari bilan strategik ittifoqlar respirator davolash vositalarini samarali targ'ib qilishga yordam beradi. Operatsion foyda marjasi tarixi ushbu jarayonlarni aniq ko'rsatadi, bunda 2.10 qiymati joriy ko'rsatkich vazifasini o'taydi. Kompaniyaning o'sish potentsiali kengaytirish imkoniyatiga asoslangan: tadqiqotlardan so'ng patentlangan dori vositalarining ommaviy ishlab chiqarilishini yo'lga qo'yish yuqori daromadlarni va'da qiladi.

TBPH - theravance.com Operatsion rentabellik 04.07.2022 - 10.10.2026 oraligʻida

Theravance Biopharma (TBPH) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:theravance.com, TBPH
Theravance Corp asosiy tovari

Investorlar aktivning operatsion kuchini xarajatlarni boshqarish samaradorligi orqali baholaydilar. Theravance Biopharma (TBPH) uchun royalti to'lovlari va patent himoyasi bu yerda asosiy omillar bo'lib, ular budjet yukini kamaytiradi. Operatsion marjani kuzatish barcha ishlab chiqarish va ma'muriy xarajatlar to'langanidan keyin qolgan daromad ulushini aniqlash imkonini beradi. Ushbu foiz biznesning soliqlar chegirilishidan oldin foyda keltirishga bo'lgan haqiqiy qobiliyatini aks ettiradi. Yuqori ko'rsatkichlar kompaniyaning tartibga soluvchi to'siqlarga nisbatan barqarorligini tasdiqlaydi.

Theravance Biopharma raqobatchilari

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.